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Curcumin is a natural dietary compound with antimicrobial activity against various gram
positive and negative bacteria. This study aims to investigate the proteome level alterations
in Bacillus subtilis due to curcumin treatment and identification of its molecular/cellular tar-
gets to understand the mechanism of action. We have performed a comprehensive proteo-
mic analysis of B. subtilis AH75 strain at different time intervals of curcumin treatment (20,
60 and 120 min after the drug exposure, three replicates) to compare the protein expression
profiles using two complementary quantitative proteomic techniques, 2D-DIGE and iTRAQ.
To the best of our knowledge, this is the first comprehensive longitudinal investigation de-
scribing the effect of curcumin treatment on B. subtilis proteome. The proteomics analysis
revealed several interesting targets such UDP-N-acetylglucosamine 1-carboxyvinyltrans-
ferase 1, putative septation protein SpoVG and ATP-dependent Clp protease proteolytic
subunit. Further, in silico pathway analysis using DAVID and KOBAS has revealed modula-
tion of pathways related to the fatty acid metabolism and cell wall synthesis, which are cru-
cial for cell viability. Our findings revealed that curcumin treatment lead to inhibition of the
cell wall and fatty acid synthesis in addition to differential expression of many crucial pro-
teins involved in modulation of bacterial metabolism. Findings obtained from proteomics
analysis were further validated using 5-cyano-2,3-ditolyl tetrazolium chloride (CTC) assay
for respiratory activity, resazurin assay for metabolic activity and membrane integrity assay
by potassium and inorganic phosphate leakage measurement. The gene expression analy-
sis of selected cell wall biosynthesis enzymes has strengthened the proteomics findings
and indicated the major effect of curcumin on cell division.
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Introduction
In spite of worldwide initiatives for the development of a plethora of synthetic and semi-syn-
thetic drugs, emerging drug resistance is still remained as one of the foremost health problems
and poses challenges for thriving combat against most of the pathogenic infections [1]. Conse-
quently, there is a growing need for the identification and characterization of new potential
drugs from natural and synthetic compounds. Natural products have continued to evolve over
thousands of years to counter various pathogenic microbes. Even today, most of the existing
antibiotics are derived from the backbone of different natural compounds [2]. B. subtilis is a
widely studied non-pathogenic gram-positive bacterium, which is often used as a model organ-
ism for diverse cellular and molecular level studies due to its genetic amenability, availability of
complete genome sequence, and easy isolation and culturing procedure.
Curcumin, chemically known as 1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-
3,5-dione, is a naturally occurring phytochemical obtained from the rhizome of Curcuma
longa. It is the polyphenolic traditional turmeric powder, which is widely used as a dietary
component. Curcumin has anti-tumor [3], anti-oxidant [4], anti-inflammatory [5], anti-geno-
toxic against the DNA damaging agents [6], phototoxic and photodynamic therapy [7,8], it
blocks the cell cycle progression in cancer cells [9] and prevents angiogenesis [10]. Curcumin
also possess anti-microbial activity against gram positive and negative bacteria and shows syn-
ergetic effects on other drugs in combination therapies [11]. Although, the diverse therapeutic
potential of curcumin has been established, its precise mechanism of action and molecular tar-
gets in prokaryotic system are mostly obscure. Recently, shikimate pathway, which is essential
for aromatic amino acid synthesis has been reported to be a possible targets of curcumin in
Helicobacter pylori [11]. Interestingly, another study indicates that curcumin can effectively
perturb the FtsZ assembly dynamics leading to elongation of the bacterial cell length and re-
duce the viability [12].
Proteome level analysis is very informative for the identification of molecular targets for de-
velopment of new antibacterial agents as well as unravelling the mechanism of action of the ex-
isting drugs, since most of the drugs act via modification/inhibition of proteins. Proteome
analysis of B. subtilis under various stress conditions, including salt stress [13], glucose starva-
tion [14], thiol-induced stress [15] and different antimicrobial drugs [16] are found to be very
enlightening. In the present study, we aimed to decipher the temporal alterations of cellular
proteome of B. subtilis AH75 strain in response to curcumin treatment at three time points
(20, 60 and 120 min). Application of two complementary quantitative proteomic techniques;
DIGE and iTRAQ in combination with high sensitive mass spectrometry effectively improved
the proteome coverage. In silico pathway analysis using DAVID and KOBAS revealed modula-
tion of fatty acid biosynthesis, peptidoglycan synthesis/ cell division, respiration and stress re-
sponse proteins in response to curcumin. In addition, gene expression analysis of cell wall and
cell division proteins confirmed the repression of cell wall biosynthesis and division. Multiple
functional assays including resazurin microtiter assay for metabolic activity, respiratory activity
assay using CTC and measurement of potassium and phosphate release after drug treatment
were performed to validate the findings obtained from proteomics analysis. Further, the real-
time interaction analysis showed that FtsZ bound to curcumin in concentration dependent
manner. This comprehensive proteomic study highlights several interesting targets involved in
pathways related to the fatty acid metabolism and cell wall synthesis perturbed by curcumin
and contributes to a better understanding of its mode of action, and potential molecular and
cellular targets.
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Results
Effect of Curcumin on B. subtilisGrowth and Cell Morphology
B. subtilis growth was measured by calculating the OD600 in the presence and absence of the
curcumin in three technical replicates (n = 3). The changes in growth pattern for 4 hrs after the
addition of the IC50 (20 μM) and MIC concentration (100 μM) of the drug have been depicted
in the Fig 1A. The growth of the cells treated with 20 μM of curcumin (IC50) was significantly
declined; whereas cultures treated with 100μM of curcumin (MIC) showed virtually no growth
compared to the untreated controls, clearly indicating the antibacterial activity of curcumin
against B. subtilis (Figs 1A and S1A). The comparison of control with and without DMSO indi-
cated no significant change in growth patterns (S1A Fig). Further, the morphological changes
in B. subtilis cells in response to curcumin treatment were investigated using fluorescent mi-
croscopy. Untreated B. subtilis cells (with and without DMSO) showed typical cell morphology
with normal size under fluorescent microscopy with single or two nucleoids per cell. Whereas,
curcumin (IC50-20 μM) treated B. subtilis cells (20, 60 and 120 min) exhibited significant alter-
ations in cell morphology; filamentous phenotype with multiple nucleoids per cell and a drastic
increase in cell length proportionally with the exposure time of the drug (Figs 1B and S1B).
Effect of Curcumin Treatment on B. subtilis Proteome Identified in
2D-DIGE and MALDI-TOF/TOF MS Analysis
Comparative analysis of control and curcumin treated [after immediate (20 min), intermediate
(60 min) and long treatment (120 min)] was performed by using 2D-DIGE, Nearly, 2000 pro-
tein spots were identified in DIA module of DeCyder software (GE Healthcare). Three sets of
analysis i.e. control vs. 20 min, control vs. 60 min and control vs. 120 min were performed sepa-
rately. Analysis of set-1 (control vs. 20 min treated) revealed differential expression of 4 protein
spots with statistical significance (p 0.05); among which 2 spots showed up-regulation and 2
spots were down-regulated. Set-II analysis (control vs. 60 min) exhibited differential expression
of 20 protein spots; among which 12 spots were up-regulated and 8 protein spots found to be
down-regulated. While the analysis of set-III (control vs. 120 min treated) revealed differential
expression of 21 protein spots, among which 10 spots were down-regulated and 11 spots were
up-regulated. Representative combined DIGE image, 3D and BVA graph views of selected dif-
ferentially expressed protein spots are displayed in the Fig 2 and S2 Fig. In 2D-DIGE analysis
(DeCyder, GE Heathcare), only the statistically significant (p 0.05; t-test and one way
ANOVA) differentially expressed (fold-change> 1.5) proteins spots were considered for sub-
sequent MALDI-TOF/TOF protein identification. All the protein spots showing differential ex-
pression in 2D-DIGE from all the three time points were excised from a preparative gel stained
with CBB and subjected to MS identification. MALDI-TOF/TOFMS and MS/MS analysis suc-
cessfully established the identity of 4 proteins in 20 min, 20 proteins in 60 min and 21 proteins
in 120 min analysis (Table 1 & S1 Table). Among these differentially expressed proteins, ATP
synthase subunit beta was common between 20 and 60 min and DNA-directed RNA polymer-
ase alpha chain protein was common between 60 and 120 min.
Effect of Curcumin Treatment on B. subtilis Proteome Revealed by
iTRAQ-based Quantitative Proteomics Analysis
iTRAQ-based quantitative proteomics analysis at all three time points of curcumin treated and
control B. subtilis using Q-TOF revealed the identification of 864 proteins in technical tripli-
cates whereas 1414 proteins were identified using LTQ- Orbitrap Velos mass spectrometer (Fig
3A and 3B). In case of iTRAQ-based quantitative proteomic analysis, only proteins with 1%
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Fig 1. Effect of curcumin treatment on the B. subtilis AH75 growth and cell morphology. (A) B. subtilis AH75 strain was grown in LB media having
spectinomycin antibiotic (100 μg/mL) till the OD600 reached to 0.1. Then the cultures were treated with DMSO (control), 20 μM (IC50 concentration) and
100 μM (MIC concentration) curcumin. Growth curve was plotted by measuring the OD600 for all the samples at every 20 min interval till 360 min (mid-
exponential phase). The three time points of curcumin treatment (20, 60 and 120 min) used in proteomic analysis are indicated by arrows. IC50 concentration
was used for subsequent proteomic analysis. (B) B. subtilis AH75 strain was grown in the presence of 20 μM (IC50 concentration) curcumin and the samples
Temporal Proteome Analysis of B. subtilis under Curcumin Treatment
PLOS ONE | DOI:10.1371/journal.pone.0120620 April 14, 2015 4 / 27
FDR were considered for analysis. Calculation of FDR is important to ensure the validity of re-
sults. Proteome Discoverer workbench allows automated calculation of false discovery rate.
Percolator (component of Proteome Discoverer 1.3) improves the sensitivity of existing data-
base search algorithms at a constant false discovery rate. Target FDR (strict), which specifies a
strict target false discovery rate for peptide matches with high confidence, was employed for
analysis. Quality of the iTRAQ data was checked by S-curve analysis of QTOF and Orbitrap
data. QTOF analysis indicated differential expression of 20%, 26% and 40% the total proteome;
while the Orbitrap analysis exhibited 6%, 17% and 40% alterations in B. subtilis proteome in 20
min, 60 min and 120 min curcumin treatment, respectively with 1.5-fold change (Fig 3C and
3D and S3 Fig). The complete list of the identified proteins from LTQ-Orbitrap and Q-TOF
along with the peptide sequence, sequence coverage, unique peptides, PSM, modifications, X
Corr and iTRAQ ratios information is provided in supplementary information (S2 Table). The
comparative quantitative proteomic analysis between QTOF and Orbitrap indicated differen-
tial expression (1.5 fold change) of 15 proteins in 20 min (8 up-regulated and 7 down-regulat-
ed), 81 proteins in 60 min (69 up-regulated and 12 down-regulated) and 210 proteins in 120
min (154 up- regulated and 56 down-regulated) of curcumin treatment with similar trend in
both of the mass-spectrometric analysis (S2 Table). In addition, we have compared the Orbi-
trap and QTOF data without any fold-change criteria. In case of Orbitrap, we identified 1414
proteins whereas in case of QTOF, we identified 864 proteins. The coverage in QTOF analysis
is quite low compared to Orbitrap analysis. In case of 20 min, 273 up-regulated proteins (39%
in Orbitrap data and 63% in QTOF data) and 229 down-regulated proteins (33% of Orbitrap
data and 60% of QTOF data) exhibited similar trend. In case of 60 min, 288 up-regulated pro-
teins (39% of Orbitrap data and 69% of QTOF data) and 246 down-regulated proteins (37% of
Orbitrap data and 66% of QTOF data) showed similar trend of differential expression. In case
of 120 min, 332 up-regulated proteins (43% of Orbitrap data and 80% of QTOF data) and 286
down-regulated proteins (45% in Orbitrap data and 75% in QTOF data) were found to be of
similar trends. The low percentage of similarity in Orbitrap data is due to the low coverage in
QTOF (S4A Fig). More than 90% proteins identified in QTOF were also identified in Orbitrap
analysis (S4B Fig). Few proteins such as 3-oxoacyl-[acyl-carrier-protein] synthase 3 protein 2,
ATP-dependent Clp protease proteolytic subunit and 60 kDa chaperonin exhibited similar
trend across the time points in both Q-TOF and LTQ-orbitrap analysis (Fig 3B and S2 Table).
In addition, comparative analysis of the findings obtained from the two complementary
techniques indicated that most of the differentially expressed protein identified in DIGE were
also detected in iTRAQ analysis (Orbitrap data), except diaminopimelate epimerase, differen-
tial expression of which was only identified in DIGE (S5A and S5B Fig). Further, the compari-
son among the time point analysis revealed that quite a few differential expressed proteins were
time point specific (S6 Fig). The MS/MS spectra of a few selected proteins along with the inset
showing the iTRAQ reporter ion intensities for representative peptides in control and curcu-
min treated (20, 60 and 120 min) samples are depicted in the Fig 3B.
Alteration of Protein Clusters after Curcumin Treatment
The global proteome analysis using both DIGE and iTRAQ characterized the physiological re-
sponses of B. subtilis to curcumin treatment. Expectedly, the differential proteomic analysis
was collected after 20, 60 and 120 min of the drug treatment. Cultures treated with only DMSOwas used as control. The nuclear materials were stained using
1 μg/μL DAPI for 20 min at room temperature in dark for all the samples. The fluorescence microscopic images were captured with both DAPI and DIC filters.
The control B. subtilis cells showed normal cell length with one or two nucleoids per cell whereas after 20, 60 and 120 min of incubation with 20 μM (IC50
concentration) curcumin, most of the cells turned into filamentous structure with multiple nucleoids. I- DIC image, II- DAPI image and III- overlay image.
doi:10.1371/journal.pone.0120620.g001
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Fig 2. Temporal proteome changes of B. subtilis under curcumin treatment identified using 2D-DIGE.Representative overlapped (Cy3 and Cy5)
2D-DIGE images of B. subtilis proteome in response to the curcumin treatment (20, 60 and 120 min). 60 μg of each sample; control, curcumin treated (20, 60
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highlighted the induction of a cluster of proteins involved in stress response; additionally al-
tered expression levels of proteins associated with cell division, sporulation and central metab-
olism. The universal chaperone proteins such as GroEL and GroES showed induction as time
of curcumin treatment increased. Chaperone-proteases required for protein folding and degra-
dation of aggregated proteins were also induced linearly with exposure time. Similarly, quite a
few cell division/sporulation and central metabolism proteins were also induced with negligible
change after 20 min but showed linear induction at 60 and 120 min treatment. Proteins associ-
ated with nucleotide biosynthesis showed repression with respect to the exposure time. In addi-
tion, quite a few proteins involved in peptidoglycan synthesis and fatty acid synthesis exhibited
linear repression in expression level with respect to curcumin treatment. The quantitation of
proteins involved in fatty acid synthesis, cell wall biogenesis, cell division, sporulation, TCA
cycle, nucleotide biosynthesis and stress physiology are summarized in the Table 2, Fig 4 and
S7 Fig.
Modulation of Biological Process and Physiological Pathways in B.
subtilis due to Curcumin Treatment
KOBAS and DAVID analysis performed with the differentially expressed proteins (1% FDR
and 1.5 fold-change) indicated immediate exposure (20 min treatment) of the drug did not af-
fect the physiological pathway significantly. Intermediate exposure (60 min treatment) of B.
subtilis to curcumin caused the alterations of TCA cycle, glyoxylate metabolism, anaerobic res-
piration, gluconeogenesis and glycine cleavage (S3 Table). Prolonged exposure of curcumin
(120 min) effectively altered the fatty acid synthesis, peptidoglycan synthesis, anaerobic respi-
ration, TCA cycle and propionate metabolism (S3 Table).
Effect of Curcumin on Respiratory Activity, Ion Leakage and Metabolic
Activity
Respiratory activity of the drug treated cells were analyzed by CTC (5-cyano-2, 3-ditolyl tetra-
zolium chloride) staining and flow cytometric analysis. CTC is a non-fluorescent dye which is
converted into red-colored fluorescent formazan in respiratory active cells. Control and curcu-
min treated (20 min, 60 min and 120 min) samples were dual stained with 5 mM CTC for 30
min at 37° C in dark followed by counter staining with DAPI. The total population of viable
cells were determined by measuring the DAPI with UV laser (358 nm) and the CTC stained
cells were measured by exciting with red florescence laser (630 nm) in FACS. Both forward and
side scattering were measured to analyze the size of the cell and to remove the contaminants re-
spectively. Curcumin treatment cells showed reduced formazan florescence with respect to the
untreated control cells, and the reduction in formazan florescence found to be increased with
the time of drug exposure. A negative control was prepared by disturbing the membrane using
2.8% formaldehyde and 0.04% glutaraldehyde for 30 min prior to the CTC staining, for which
the CTC intensity was almost zero (Fig 5A).
The extracellular inorganic phosphate and potassium levels were monitored at different
time intervals of curcumin exposure using ICP-AES. The extracellular K+ and P levels of curcu-
min treated cells (both IC50 and 2 x IC50) found to be increased with respect to the untreated
control cells. Nearly three times increase in the extracellular K+ leakage was observed after 20
and 120 min) and internal standard were labelled with Cy3, Cy5 and Cy2, respectively (Dye swapping was performed). Proteins were separated in first
dimension IEF on 24 cm IPG strips of pH 4–7 range followed by second dimension separation on 12.5% SDS-PAGE. 3D view and BVA graphs of selected
differentially expressed proteins (p < 0.05) identified from each time point of curcumin treatment in 2D-DIGE are shown. Data is represented as mean ± SE
(where n = 3).
doi:10.1371/journal.pone.0120620.g002
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20 min curcumin treatment
D-1* P37809 ATP synthase subunit beta AtpD 51.42 19 -1.56 NS NS 662 423 0.032
D-2 P80698 Trigger factor Tig 47.48 11 -1.78 -1.21 -1.25 579 426 0.039
U-1* P46336 Protein IolS IolS 35.17 13 1.85 NS 2.39 167 104 0.01
U-2 O31605 Oligoendopeptidase F
homolog
YjbG 77.07 4 1.78 1.59 1.58 109 85 0.019
60 min curcumin treatment
D-1* P37253 Ketol-acid reductoisomerase IlvC 37.43 19 -1.67 NS NI 1240 1163 0.043
D-2* P42973 Aryl-phospho-beta-D-
glucosidase BglA
BglA 54.84 18 -1.69 NS NS 266 229 0.04
D-3 # O32114 Diaminopimelate epimerase DapF 30.85 4 -1.72 NI NI 109 100 0.0067
D-4* P20429 DNA-directed RNA
polymerase alpha chain
RpoA 34.77 13 -1.95 NS -1.42 245 200 0.029
D-5* P22250 Glutamate—tRNA ligase GltX 55.72 36 -2.23 NS NS 783 648 0.026
D-6 Q07836 Uncharacterized protein
yxxG
YxxG 16.43 4 -2.72 -1.61 -5.00 274 207 0.027
D-7 P80868 Elongation factor G FusA 76.62 50 -5.01 -1.45 -1.48 1120 889 0.041
D-8 P80868 Elongation factor G FusA 76.62 49 -5.92 -1.45 -1.48 1090 884 0.014
U-1 O32201 Protein LiaH LiaH 25.69 31 17 6.63 2.23 788 663 0.0017
U-2* P21464 30S ribosomal protein S2 RpsB 27.96 15 4.22 NS -1.34 601 534 0.00026
U-3 P49814 Malate dehydrogenase Mdh 33.64 13 2.97 2.17 1.63 628 586 0.047
U-4* P80866 Vegetative protein 296 YurY 29.03 9 2.95 NS NS 110 96 0.035
U-5* P17820 Chaperone protein dnaK DnaK 66 29 2.79 NS NS 1000 793 0.0041
U-6 P54550 Probable NADH-dependent
flavin oxidoreductase yqiM
YqiM 37.58 14 2.33 1.37 2.82 513 463 0.05
U-7 P80864 Probable thiol peroxidise Tpx 18.31 10 2.18 1.56 1.52 303 233 0.0053
U-8 P96611 Thioredoxin-like protein
ydbP
YdbP 12.43 5 2.11 1.39 1.39 120 102 0.032
U-9* P49778 Elongation factor P Efp 20.47 7 2.07 NS NS 203 175 0.032
U-
10*
P37809 ATP synthase beta chain AtpD 51.42 29 1.96 NS NS 1350 1192 0.045
U-11 O35022 FMN-dependent NADH-
azoreductase 1
AzoR1 22.98 17 1.78 1.85 NI 436 391 0.036
U-12 P28599 10 kDa chaperonin GroS 10.17 5 1.51 1.81 1.65 157 122 0.038
120 min curcumin treatment
D-1 P23630 Diaminopimelate
decarboxylase
LysA 48.7 18 -3.64 -1.35 -1.51 482 414 0.0034
D-2 P30950 Delta-aminolevulinic acid
dehydratase
HemB 36.2 4 -3.57 -1.52 -1.33 146 102 0.012
D-3 P32395 Uroporphyrinogen
decarboxylase
HemE 39.64 3 -3.57 -1.29 1.62 208 164 0.039
D-4 P54419 S-adenosylmethionine
synthetase
MetK 44 10 -1.67 -2.33 -2.45 104 83 0.0079
D-5* P39121 Deoxyribose-phosphate
aldolase
DeoC 22.19 6 -2.35 NS NS 175 150 0.0045
D-6 P05654 Aspartate
carbamoyltransferase
PyrB 34.31 16 -2.29 -1.94 NI 468 373 0.028
D-7 P52996 3-methyl-2-oxobutanoate
hydroxymethyltransferase
PanB 30 3 -1.94 NS -1.92 328 284 0.037
(Continued)
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min exposure of curcumin and the levels were remained unaltered with respect to the untreated
control as time of curcumin exposure increased to 120 min. Moreover, inorganic phosphate
levels were found to be increased with the increase in exposure time of curcumin from 20 min
to 120 min. In case of positive control (the cells were heated at 70° C for 30 min), the extracellu-
lar K+ and P levels were found to be higher compared to the untreated control; the similar
trend as exhibited by the curcumin treated samples. Two different concentrations of curcumin
were used to monitor extracellular K+ and P levels, but no significant difference was observed
between the IC50 and 2 x IC50 concentrations of the drug (Fig 5B and 5C).
Non-fluorescent resazurin blue dye is converted into pink resorufin by the active metabolic
enzymes from central metabolism in the viable cells. B. sublitis cells treated with curcumin ex-
hibited reduced metabolic activity at the immediate exposure (20 min) of curcumin whereas
the metabolic activity was found to be increased at the intermediate (60 min) and long expo-
sure (120 min) of the drug as compared to untreated control cells (Fig 5D).
Gene Expression Analysis using RT-PCR and SPR Interaction Analysis
The quantitative gene expression analysis of three selected candidates includingmurAA
(UDP-N-acetylglucosamine 1-carboxyvinyltransferase 2), spoVG (putative septation protein
SpoVG) and ftsH (ATP-dependent zinc metalloprotease FtsH) associated with cell division was





















D-8* P21882 Pyruvate dehydrogenase E1
component subunit beta
PdhB 35.47 26 -1.69 NS NS 317 171 0.015
D-9* Q9KWU4 Pyruvate carboxylase Pyc 127.9 30 -2.75 NS NS 315 188 0.0012
D-10 O32117 NADH dehydrogenase-like
protein yutJ
YutJ 39.75 19 -2.28 -1.51 NI 865 737 0.014
U-1 P80244 ATP-dependent Clp
protease proteolytic subunit
ClpP 21.6 5 1.63 2.26 2.35 323 241 0.05
U-2* P21880 Dihydrolipoyl
dehydrogenase
PdhD 49.7 20 1.67 NS -1.24 996 929 0.024
U-3* P20429 DNA-directed RNA
polymerase alpha chain
RpoA 34.77 13 2 NS -1.28 245 200 0.029
U-4 P81101 Ribosome recycling factor Frr 20.62 10 2.56 1.50 1.56 346 273 0.047
U-5 O32259 Lactate utilization protein C LutC 26.27 6 2.58 1.26 NS 223 199 0.02
U-6* P37487 Manganese-dependent
inorganic pyrophosphatase
PpaC 34 4 2.6 NS NS 379 283 0.04
U-7 P28598 60 kDa chaperonin GroL 57.25 25 2.84 2.10 1.95 1340 1224 0.048
U-8 P15874 GrpE protein (HSP-70
cofactor)
GrpE 21.53 6 3.98 1.50 NS 186 167 0.023





DeoC 23.47 13 1.72 NS NS 611 524 0.041
U-11 P09339 Aconitate hydratase CitB 99.61 28 4.13 4.56 3.88 789 664 0.0015
$ This is a partial list having selected candidates with >1.5 fold change and complete list is provided in S2 Table
#: Proteins unique in DIGE, Bold: Same trend in both DIGE and iTRAQ (Orbitrap data);
* or NS: No significant change in iTRAQ in Orbitrap data (less than 1.2 fold up and down);
NI- Not identified in iTRAQ analysis.
doi:10.1371/journal.pone.0120620.t001
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significant elevation in their expression at transcriptome levels, which is consistence with the
proteomic data; whereasmurAA exhibited elevated expression at mRNA level after curcumin
treatment, but showed reverse trend of differential expression in proteomic analysis (Fig 5E).
The SPR-biosensor based interaction analysis has showed very good binding of curcumin
with FtsZ and the interaction was measured by calculating the response unit (RU). Eight differ-
ent concentrations of curcumin was used for interaction analysis and all the concentrations
showed binding of curcumin to the FtsZ in concentration-dependent manner i.e. as the con-
centration of curcumin increases, the observed response unit was also increased linearly. The
Fig 3. Schematic representation of experimental strategy for temporal proteome analysis of B. subtilis under curcumin treatment by iTRAQ-based
quantitative proteomics. (A) Samples processed in triplicate were pooled from control, 20, 60 and 120 min curcumin treated cultures and labelled with
iTRAQ reagent 114, 115, 116 and 117, respectively. The labelled peptides were fractionated in OFFGEL fractionators using high resolution (24 cm; 3–10 pH)
IPG strips and each fraction was desalted using C18 tips. Desalted fractions were subjected to LTQ-Orbitrap Velos mass spectrometer for protein
identification and quantitation. (B) Representative MS/MS spectrum of a few selected differentially expressed proteins identified after curcumin treatment.
UDP-N-acetylglucosamine 1-carboxyvinyltransferase 1 (MurAA), ATP-dependent zinc metalloprotease FtsH, Septum site-determining protein (DivIVA), and
3-oxoacyl-[acyl-carrier-protein] synthase 3 protein 1 (FabHB). Inset showing the iTRAQ reporter ion intensities for representative peptides in control and
curcumin treated samples. (C) S-curve analysis exhibiting distribution of the differentially expressed proteins in B. subtilis after 20, 60 and 120 min of
curcumin treatment identified using Q-TOF (average of three triplicate runs). (D) S-curve analysis exhibiting distribution of the differentially expressed
proteins in 20, 60 and 120 min curcumin treated B. subtilis identified using LTQ-orbitrap.
doi:10.1371/journal.pone.0120620.g003
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Table 2. Partial list of differentially expressed proteins in B. subtilis due to curcumin treatment obtained from iTRAQ analysis*.
UniProt
ID


























MurAA 35.32 13 0.89 0.64 0.41 13 1.36 0.702 0.549
Q03522 UDP-N-acetylmuramoylalanine—D-
glutamate ligase
MurD 31.04 13 0.98 0.67 0.47 4 1.115 1.039 0.812
P40778 UDP-N-acetylmuramate—L-alanine ligase MurC 25.46 9 1.03 0.71 0.54 6 1.296 1.170 0.580
Q03523 UDP-N-acetylmuramoyl-L-alanyl-D-
glutamate—2,6-diaminopimelate ligase





MurG 37.47 11 0.91 0.8 0.63 3 0.693 0.682 0.462
P94556 Glutamate racemase 1 RacE 25.37 4 0.97 0.84 0.68 2 0.773 0.857 0.539
P96613 UDP-N-acetylmuramoyl-tripeptide—D-
alanyl-D-alanine ligase
MurF 30.20 8 1.10 0.79 0.87 3 1.721 0.934 0.846
P0CI73 Glutamine—fructose-6-phosphate
aminotransferase [isomerizing]
GlmS 30.33 15 0.92 0.79 0.53 10 0.891 0.761 0.535
P14192 Bifunctional protein GlmU GlmU 23.03 8 0.93 0.83 0.58 7 2.139 1.505 0.885
Cell division and Sporulation
P45693 Stage V sporulation protein S SpoVS 38.37 2 1.10 2.59 6.10 3 3.703 4.052 6.623
P28015 Putative septation protein SpoVG SpoVG 42.27 4 0.96 1.51 4.49 2 0.912 0.712 2.091
Q07867 Cell division protein FtsL FtsL 8.55 1 0.72 1.41 3.09 NI NI NI NI
P0CI74 Cell cycle protein GpsB GpsB 43.88 4 0.98 1.06 1.46 2 1.173 1.452 1.772
P06628 Sporulation initiation phosphotransferase F SpoOF 23.39 2 0.79 1.75 2.93 2 0.566 1.686 2.371
Q01368 Stage III sporulation protein AB SpoIIIAB 5.26 1 0.89 1.29 2.02 NI NI NI NI
P06534 Stage 0 sporulation protein A SpoOA 13.86 3 0.97 1.33 2.09 1 1.158
P71088 Sporulation-control protein spo0M SpoOM 37.21 10 1.23 1.00 1.61 5 1.446 0.986 0.877
P39624 Spore coat polysaccharide biosynthesis
protein SpsD
SpsD 4.84 1 0.97 0.43 1.13 NI NI NI NI
P37470 Peptidyl-tRNA hydrolase SpoVC 13.83 2 1.10 0.82 0.61 2 2.023 0.587 0.877
Fatty acid synthesis
O34746 3-oxoacyl-[acyl-carrier-protein] synthase 3
protein 1
FabHA 45.83 13 1.01 0.56 0.38 6 0.914 0.584 0.438
O07600 3-oxoacyl-[acyl-carrier-protein] synthase 3
protein 2
FabHB 18.15 6 0.94 0.54 0.41 2 1.079 0.407 0.480
P71019 Malonyl CoA-acyl carrier protein
transacylase
FabD 48.26 14 0.93 0.64 0.44 13 0.976 0.620 0.564
P54616 Enoyl-[acyl-carrier-protein] reductase
[NADH] FabI
FabI 51.16 11 0.91 0.65 0.54 6 0.975 0.905 0.787
O34340 3-oxoacyl-[acyl-carrier-protein] synthase 2 FabF 48.67 14 1.03 0.73 0.57 11 1.146 0.858 0.818
P51831 3-oxoacyl-[acyl-carrier-protein] reductase
FabG
FabG 61.79 12 1.01 0.71 0.58 7 1.318 0.912 0.794
Stress response
P37571 Negative regulator of genetic competence
ClpC/MecB
ClpC 59.88 45 1.20 1.65 2.43 29 1.264 1.809 2.746
P80244 ATP-dependent Clp protease proteolytic
subunit
ClpP 43.15 8 1.09 2.07 2.26 4 1.283 2.136 2.208
(Continued)
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P39778 ATP-dependent protease ATPase subunit
ClpY
ClpY 35.55 14 1.17 1.41 1.82 5 1.835 1.589 2.231
O31673 ATP-dependent Clp protease ATP-binding
subunit ClpE
ClpE 16.17 5 0.95 1.72 1.76 NI NI NI NI
P39070 ATP-dependent protease subunit ClpQ ClpQ 21.55 4 1.13 1.08 1.61 NI NI NI NI
P54617 Phage shock protein A homolog YdjF 58.59 11 0.76 1.22 3.09 6 1.065 1.472 2.324
P54375 Superoxide dismutase [Mn] SodA 67.82 9 1.11 1.59 2.69 6 1.148 1.224 2.161
P42297 Universal stress protein YxiE YxiE 45.27 5 1.19 0.95 2.34 3 0.901 0.859 1.609
P51777 Cold shock protein CspD CspD 89.39 5 0.92 1.22 2.25 3 0.920 1.452 1.325
P28599 10 kDa chaperonin GroS 73.40 7 1.09 1.82 2.20 5 1.329 1.824 2.662
P28598 60 kDa chaperonin GroL 74.63 39 1.07 1.69 2.10 24 1.187 1.885 2.289
P39158 Cold shock protein CspC CspC 59.09 5 0.22 0.82 1.86 1 0.304 0.863 1.842
P81100 Stress response protein SCP2 YceC 37.69 6 1.05 1.30 1.74 2 1.381 1.308 2.002
P54377 Probable glycine dehydrogenase
[decarboxylating] subunit 2
GcvPB 9.43 3 1.20 2.15 1.67 1 0.693 2.848 2.690
O32221 Copper chaperone CopZ CopZ 68.12 3 0.66 1.04 1.63 1 1.427 0.873
P15874 Protein GrpE GrpE 57.75 10 0.96 1.13 1.51 5 1.399 1.455 1.497
P80875 General stress protein 16U YceD 49.74 6 1.05 1.30 1.50 6 1.085 1.542 1.672
TCA cycle
P39120 Citrate synthase 2 CitZ 31.18 11 1.20 3.99 7.65 7 1.621 3.706 8.131
P09339 Aconitate hydratase CitB 33.22 25 1.14 3.94 4.56 12 2.032 4.297 4.724
P39126 Isocitrate dehydrogenase [NADP] Icd 44.21 20 1.10 3.06 3.53 9 2.008 2.694 3.139
P23129 2-oxoglutarate dehydrogenase E1
component




OdhB 54.44 18 1.18 2.51 3.30 13 2.203 4.063 3.053
P80865 Succinyl-CoA ligase [ADP-forming] subunit
alpha
SucD 33.00 6 1.12 2.73 3.39 4 1.553 2.023 3.060
P80886 Succinyl-CoA ligase [ADP-forming] subunit
beta
SucC 55.32 22 1.11 3.26 4.08 15 1.252 5.002 4.043
P08065 Succinate dehydrogenase flavoprotein
subunit
SdhA 49.32 22 1.44 2.40 2.06 9 1.061 2.320 2.220
P08066 Succinate dehydrogenase iron-sulfur
subunit
SdhB 27.27 6 1.33 2.14 1.71 3 1.347 2.216 1.813
Nucleotide biosynthesis
P29726 Adenylosuccinate synthetase PurA 26.05 10 1.12 0.76 0.55 7 1.189 0.814 1.119
P12047 Adenylosuccinate lyase PurB 35.27 15 0.95 0.77 0.45 4 0.966 0.722 0.535
P12046 Phosphoribosylaminoimidazole-
succinocarboxamide synthase
PurC 4.98 1 0.61 0.95 0.62 NI NI NI NI
P12039 Phosphoribosylamine—glycine ligase PurD 12.56 4 0.72 0.91 0.62 NI NI NI NI
P12044 N5-carboxyaminoimidazole ribonucleotide
mutase
PurE 19.75 2 0.81 1.02 0.57 2 0.740 0.761 1.417
P12048 Bifunctional purine biosynthesis protein
PurH
PurH 27.54 11 0.66 0.98 0.56 5 0.491 1.212 0.584
P12042 Phosphoribosylformylglycinamidine
synthase 2
PurL 3.10 2 0.55 0.82 0.53 NI NI NI NI
(Continued)
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duplicates (40 μM) have showed similar response with FtsZ, which indicates the good quality
of the data (Fig 5F).
Discussion
Differential proteomic analysis is found to be very effective for comprehensive analysis of mi-
crobial responses to different environmental stress conditions and drug treatments. Previous
studies have demonstrated anti-tumergenic, anti-inflammatory, anti-mutagenic and anti-oxi-
dant activities of curcumin [3,5]. Although, quite a few earlier studies have investigated the ef-
fect of curcumin on B. subtilis, the mechanism of action of the drug and its role in
filamentation as well as exact molecular targets are still unclear and proteome level analysis has
not been performed hitherto. To the best of our knowledge, we report here the first compre-
hensive proteomic analysis describing the effect of curcumin on B. subtilis proteome to under-
stand the mode of action of curcumin and its primary cellular targets. The first and foremost
comprehensive proteome mapping of B. subtilis was reported by Eymann et al. using classical
2-DE and obtained coverage was 745 proteins [17]. Later Wolff et al. have improved the cover-
age to 1218 proteins using a combination of 2-DE and iTRAQ [18]. In the present study, we
were able to cover 1466 proteins using both DIGE and iTRAQ-based quantitative proteomics,
which covered almost 60% of the entire vegetative proteome of B. subtilis. The present study
demonstrates the application of temporal quantitative proteome analysis to understand the
mechanism of action and possible targets of curcumin in B. subtilis. The altered proteins were
found to be majorly involved in bacterial cell division, cell wall biosynthesis, fatty acid synthesis
and central metabolism. In addition, the universal chaperone system (GroEL) required for
FtsZ folding and the major protease (Clp family) system target FtsZ for degradation has been
altered. We would also like to mention that this is the foremost global study contributing to un-
derstand the mechanism of action and putative targets of curcumin in B. subtilis.
Our proteomic analysis revealed modulation of quite a few members of cell wall biosynthe-
sis and cell division machinery proteins. Peptidoglycan cross-linking is the major scaffold in
cell wall to provide the strength and maintain the cell shape along with shape determining pro-
teins [19]. Cell wall and cell division proteins express together to correlate the division with cell
wall synthesis which reside in the division cell wall (DCW) cluster. Quite a few cell wall synthe-
sizing proteins of DCW cluster were found to be repressed at the intermediate and long expo-
sure of curcumin, whereas cell division proteins were slightly induced indicating that
individual promoters up-stream to the each gene are affected, but the common promoter of
DCW cluster probably remained unaffected [20]. MurAA, which catalyzes the first step in pep-



























P29727 GMP synthase [glutamine-hydrolyzing] GuaA 58.67 27 1.03 0.64 0.42 17 1.162 0.714 0.538
O05269 GMP reductase GuaC 48.16 10 1.06 1.00 0.49 4 1.766 2.612 1.020
P14193 Ribose-phosphate pyrophosphokinase Prs 35.65 11 0.93 0.74 0.52 8 0.889 0.884 0.707
* This is a partial list having selected candidates; complete list is provided in S2 Table
NI- Not identified in Q-TOF
doi:10.1371/journal.pone.0120620.t002
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and also coordinate in cell division, was found to be repressed after curcumin treatment (Fig
6). Even though, MurAA protein level was repressed under curcumin treatment, its mRNA
level expression was found to be elevated (Fig 5E). In order to find out the rationale behind this
observation, expression levels of different proteins which have direct or indirect influence on
Fig 4. Quantitative profiles of the differentially expressed proteins involved in diverse biological processes identified in iTRAQ-based quantitative
proteomics analysis using LTQ-Orbitrap. (A) Peptidoglycan biosynthesis, (B) Fatty acid synthesis, (C) Cell division and sporulation, (D) TCA cycle, (E)
Stress response and (F) Nucleotide biosynthesis. Data from QTOF is provided in the S2 Fig.
doi:10.1371/journal.pone.0120620.g004
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Fig 5. (A) CTC staining and flow cytometric analysis for respiratory activity.Graphical representation of CTC mean intensity (PE-Texas Red-A) vs.
FSC-A obtained in the FACS analysis of control, 20, 60 and 120 min curcumin treated samples and negative control. Both dot plot and histogram
representations are displayed for each sample. (B) & (C) Potassium and phosphorus leakage assay; curcumin (20 and 40 μM) was added to the B. subtilis in
HEPES-glucose medium and K+ and P levels were measured at 20, 60, 90 and 120 min time intervals, and also in the untreated control and positive control
(heated at 70° C for 30 min) samples using ICP-AES and data was normalized with baseline HEPES-glucose medium. (D)Metabolic activity assay using
resazurin. 20 min curcumin treatment has showed lower metabolic activity whereas the metabolic activity increased as time of exposure increased to 60 min
and 120 min as compared to control. * indicates p < 0.05. (E)Gene expression analysis using RT-PCR formurAA, spoVG and ftsH genes and the relative
expression was calculated by taking mean Ct values from triplicate runs. * indicates p < 0.05 and ** indicates p < 0.001. (F) Physical interaction analysis of
curumin with B. subtilis FtsZ immobilized on CM-5 sensor chip. The interaction was monitored by measuring the response unit and the response unit was
increased as the concentration of curcumin increased. Both sensorgram and the bar diagram showing the binding to FtsZ was displayed.
doi:10.1371/journal.pone.0120620.g005
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MurAA expression at the protein level were analyzed carefully. Interestingly, we identified ele-
vated level of ClpCP, which is a proteolytic enzyme causing degradation of MurAA during the
60 and 120 min of curcumin exposure [20]. In addition, GlmS and GlmU, two crucial enzymes
required for cell wall synthesis have been found to be repressed; GlmS is also a target of ClpC
[14] and its down-regulation may be a consequence of elevated cellular level of ClpCP. Addi-
tionally, cell wall stress specific marker protein like protein LiaH was also found to be induced
under curcumin treatment; probably to protect the survival of the bacteria despite hampered
cell wall biosynthesis under the stress condition. Induction of YdjF and YtrB proteins, which
are marker proteins of cell wall damage and help in stabilizing the cell envelop, was also ob-
served [21]. Interestingly, MreBH, MreB and Mbi, the major proteins involved in cell morpho-
genesis, were also found to be repressed at the late stages of curcumin treatment. Earlier studies
have demonstrated that MreB knockouts strains and reduced expression of MreHB and Mbi
lead to the filamentous cell morphology [22,23]. Further, FtsL-DivIB and MinJ proteins, which
play an important role in the late stage vegetative septum and asymmetric septum formation
during sporulation [24–27] were slightly induced due to the curcumin treatment. Further,
Fig 6. Modulation of essential physiological pathways in B. subtilis due to curcumin treatment. The pathway was built based on DAVID, KEGG and
KOBAS analysis and the combined pathway was built manually. Red bar or name indicates down-regulation and blue bar and name indicates up-regulation.
The three bars indicate the protein expression at 20, 60 and 120 min of curcumin treatment (expression levels obtained from LTQ-Orbitrap analysis). PRPP-
5-Phospho-alpha-D-ribose 1-diphosphate; GAR-5'-Phosphoribosylglycinamide; FGAM-5'-Phosphoribosyl-N-formylglycinamidine; CAIR-5'-Phosphoribosyl-
5-amino-4-imidazolecarboxylate; SAICAR-5'-Phosphoribosyl-4-(N-succinocarboxamide)-5-aminoimidazole; AICAR-5-Phosphoribosyl-4-carbamoyl-
5-aminoimidazole; FAICAR-5'-Phosphoribosyl-5-formamido-4-imidazolecarboxamide; IMP-Inosine monophosphate.
doi:10.1371/journal.pone.0120620.g006
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ATP-dependent zinc metal protease (FtsH) that degrades the peptidoglycan layer and main-
tains lipid homeostasis during vegetative and sporulation was slightly induced at intermediate
and late exposure. Gene expression analysis of FtsH also showed similar trend of induction at
the transcription level probably to enhance the asymmetric division [28]. Interestingly, the
SpoVG, asymmetric division regulator proteins were induced both at protein and transcrip-
tome levels [29]. The induced late cell division proteins and sporulation proteins indicate the
asymmetric division as an alternative of vegetative septum. Besides, Rai et al. showed that cur-
cumin treatment severally perturbs the FtsZ polymerization dynamics required for the cell di-
vision and leads to filamentation. The biosensor-based interaction analysis has also showed
binding of curcumin with FtsZ at the molecular level and may halt the function of polymeriza-
tion (Fig 5F). Therefore, we anticipate that apart from disturbing the FtsZ polymerization, cur-
cumin also affects the expression of cell division accessory proteins [12].
Since diverse classes of proteins associated with cell division and cell wall synthesis process
were found to be deregulated due to the curcumin treatment, we were interested to verify the
expression levels of molecular chaperones, which support the folding of the proteins. Clp pro-
teins are highly conserved protease system in eubacteria and constitute ClpC, ClpX, ClpE,
ClpY, ClpQ and ClpP in B. subtilis [30]. These proteins are generally induced under stress con-
ditions and recognize the unfolded proteins, while ClpP is the proteolytic core, which degrades
the unfolded proteins [31]. The increased expression levels of the multiple members of Clp
family under curcumin treatment indicate aggregations or unfolding of the proteins in the cell.
Additionally, Clp family has important role in cell division because FtsZ is one of the prime tar-
gets for ClpP, sporulation, motility and other physiological processes [32]. Similar results were
reported previously indicating an increased expression of ClpP causes the degradation of FtsZ
through its proteolytic activity and consequently promotes cell elongation [31]. We anticipate
that the elevated levels of Clp family can target the cell division proteins and promote the elon-
gation. However, GroEL and GroES, one of the major chaperon and co-chaperon systems in B.
subtilis were found to be elevated due to curcumin treatment. GroL is a 60 kDa chaperonin sys-
tem and GroS is a 10 kDa protein, which plays a fundamental role in protein folding and is
considered to be highly conserved among eubacteria. A previous study by Kerner et al., demon-
strated that GroEL system has more than 85 substrates involved in various physiological path-
ways in E. coli [33]. GroEL system is also involved in folding of cell division proteins such as
FtsZ, FtsA, FtsI and FtsE proteins [34]. Increased level of GroEL might be due to the mis-fold-
ing of the essential cell division proteins under curcumin treatment leading to an urgent need
for the excess of chaperone to repair the system. Moreover, GroEL is localized at the centre of
the cell and its localization strictly depends on FtsZ. Possibly, GroEL system plays a role in sta-
bilizing the FtsZ for polymerization or in the recruitment of accessory proteins to the division
site necessary for septa formation [35]. Apart from GroEL, GrpE, which also plays an impor-
tant role in preventing aggregation of unfolded proteins [35], was found to be elevated after
curcumin treatment along with the other stress proteins probably to stabilize the growth under
stress condition.
In addition to the alteration of the cell division and cell wall synthesis, multiple vital anabol-
ic and catabolic pathways in B. subtilis were found to be altered under curcumin treatment. Ele-
vated expression levels of multiple components of the central carbon metabolism pathways,
including most of the TCA cycle enzymes were observed, particularly during the late phases of
drug exposure probably to provide the sufficient energy precursors for survival of the microor-
ganism under adverse conditions (Fig 6). Consequently, PP pathway and other carbohydrate
metabolism were also induced to provide the sufficient precursors for nucleotide biosynthesis
(Fig 6). Interestingly, the expression level of S-adenosyl methionine synthase involved in syn-
thesis of S-adenosyl methionine (SAM), which is one of the crucial co-factor involved in
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multiple vital cellular processes, was found to be reduced. In E. coli, it has been reported that
SAM plays a vital role in methylating the late cell division proteins for recruitment to division
site and deletion of the S-adenosyl methionine synthase causes elongation of the cells [36,37].
The reduced levels of SAM synthase suggest a similar effect on the late cell division proteins
which may induce the elongation process. Additionally, cell membrane plays a crucial role in
maintaining the membrane potential and PMF to generate energy. Fatty acid synthesis is essen-
tial for phospholipids and lipid bilayer synthesis, which is in-tern linked to the cell membrane
permeability (Fig 6). Curcumin treatment significantly affected the expression of fatty acid syn-
thesizing enzymes in correlation to the time of exposure, which indicates that reduced synthe-
sis of fatty acids/phospholipid is required for the cell membrane [38,39] (Fig 4). Moreover, the
functional assays clearly indicated the alteration of membrane permeability and lower respira-
tory activity under curcumin treatment (Fig 5A–5D). Recent studies also highlighted that
membrane potential or PMF (proton motive force) is essential for the localization of cell divi-
sion proteins towards the division site [40–42]. Additionally, membrane damage or membrane
stress marker proteins such as phage shock protein A homolog (YdjF) and NH(3)-dependent
NAD(+) synthetase (NadE) were found to be induced under curcumin treatment. Interestingly,
similar responses were reported earlier with cell membrane targeting lantibiotics [21] indicat-
ing there might be some level of similarities in the mode of action of these antimicrobials.
Quite a few bio-physical and global proteome analyses of eukaryotic systems have been re-
ported earlier to elucidate the mechanism of action of curcumin [43–46]. Even though the in-
hibitory concentration of curcumin required for bacteria and tumor cell lines are almost
similar, curcumin is still considered as a potent antimicrobial compound due to two important
reasons: firstly, curcumin is a very safe compound and human body can take up to 12g of cur-
cumin/day and secondly, the poor bioavailability of curcumin in humans under physiological
conditions [47, 48]. Therefore, the inhibitory concentration of curcumin required for restrain-
ing the microorganisms in vivo cannot adversely affect the host system.
In summary, this is the first comprehensive proteomic study indicating the modulation of
cell wall synthesis, cell division, chaperones and central metabolism in B. subtilis due to curcu-
min treatment. Our findings indicate that inhibition of the cell division machinery is one of the
prime targets of this drug; since, multiple proteins involved in cell division process such as
FtsH, FtsL, MinJ, GpsB and DivIB were found to be differentially expressed as a consequence
of the curcumin treatment. In addition, cell membrane permeability/potential has been affected
drastically due to repression of fatty acid synthesizing enzymes which is further supported by
reduced respiratory activity and leakage of ions. Quite a few earlier studies have highlighted
that the membrane permeability or potential is essential for cell division by supporting the divi-
sion proteins at the septum site. To this end, a detailed investigation of the functional proper-
ties of these differentially expressed proteins in the context of cell division will be useful to
enhance our understanding regarding the mechanism of action of this potential
antibacterial agent.
Materials and Methods
Growth Curve Analysis of B. subtilis under Curcumin Treatment
The present study was carried out with B. subtilis AH75 strain having a spectinomycin antibi-
otic marker [49]. Cultures were grown overnight at 370 C in LB medium containing 100 μg/mL
spectinomycin. The overnight culture was re-inoculated in fresh media with a final OD of 0.05
(at 600 nm) to adjust the cell population at 106/mL. Growth of B. subtilis cultures were contin-
ued at 37° C in the absence and presence of IC50 (20μM) and MIC (100μM) concentrations of
curcumin. The growth of the B. subtilis cultures was monitored by measuring the OD at 600
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nm of an aliquot after every 20 min interval and continued up to 360 min (mid-exponential
phase). This experiment was carried out in triplicates and the growth curve was plotted with
mean values and standard deviation.
Culture Conditions and Microscopic Analysis
Overnight cultures were sub-cultured into fresh LB media with sufficient amount of inoculums
to get the final OD600 at 0.1 and further incubated again at 37
°C till the OD600 reached to 0.2.
Curcumin stock solution 500 mM (Sigma, St. Louis, MO, USA) was prepared in DMSO. Cur-
cumin (IC50- 20 μM) was added to the bacterial cultures having 0.2 OD600 and subsequently in-
cubated at 37°C. Control cultures were grown under the identical condition i.e. in the presence
of the solvent (DMSO), but without the curcumin. Curcumin treated samples (10 mL each)
were harvested at 20, 60 and 120 min of the drug treatment by centrifuging at 7000 rpm for 10
min at 4°C. The cells were fixed with 2.8% formaldehyde and 0.04% glutaraldehyde at 37°C for
30 min after washing with PBS buffer for 3 times. DAPI staining was performed by adding
1μg/μL concentration to the fixed cells for 20 min in dark. Morphological changes were ob-
served under a fluorescence microscope (Axio observer Z1 microscope using Axiovision soft-
ware, Zeiss) using 100 X objective.
Sample Preparation fromWhole Cell Extract
Protein extraction was performed from control and curcumin (20, 60 and 120 min treatment)
treated B. subtilis AH75 strains using TRIzol extraction protocol [50]. Briefly, the bacteria were
harvested at different time points of curcumin exposure (20, 60 and 120 min) and untreated
control samples and washed with PBS buffer (pH 7.4) for 4 times to remove the media compo-
nents. Cell lysis was performed with lysozyme (1 mg/mL) and sonication in presence of prote-
ase inhibitor cocktail (GE Healthcare). To the cell lysates, TRIzol and chloroform were added
to remove RNA, and ethanol was added to remove DNA and chilled acetone was added to pre-
cipitate protein. Protein pellet was washed with guanidine-HCl and acetone to remove the phe-
nol and salts. Protein pellets were air dried and finally dissolved in rehydration buffer
containing 7 M urea, 2 M thiourea, 2% CHAPS (w/v) and traces of bromophenol blue. The
protein concentration in each sample was measured using 2-D quant kit (GE healthcare) fol-
lowing the manufacturer’s instructions.
Cy Dye Labelling and 2D-DIGE
Control and all three time points (20, 60 and 120 min) of curcumin treated samples were sub-
jected to quantitative 2D-DIGE analysis. Prior to labelling, pH of the protein samples were ad-
justed to 8.5 with 100 mMNaOH. 60μg of each protein sample (control and all three time
points of curcumin treated and internal standard) were individually labelled with 400 pmol of
CyDyes (GE Healthcare). Subsequent to addition of CyDyes, samples were incubated on ice for
1 hr in the dark. Labelling reaction was stopped by addition of 10 mM lysine followed by addi-
tional 10 min incubation on ice. Dye-swapping was carried out while labelling the test and con-
trol samples to get rid of dye selection biasness. The details of labelling strategy are provided in
S4 Table. Samples labelled with Cy3, Cy5 and Cy2 were mixed, diluted with the rehydration
buffer having 1% DTT and 1% IPG buffer and loaded on 24 cm, 4–7 pH IPG strips and rehy-
dration was performed for 14 hrs at room temperature. Isoelectric focussing and SDS-PAGE
was performed with the settings described previously by Reddy et al., [50].
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Image Acquisition and DeCyder Analysis
Image acquisition and data analysis of 2D-DIGE gels were performed as described previously
[51]. In brief, the 2D-DIGE gels were scanned at a 100 μm resolution using a Typhoon FLA
9500 biomolecular imager (GE healthcare) using suitable excitation/emission wavelengths for
each of the CyDye (Cy3 (523/580nm), Cy5 (633/670nm) and Cy2 (488/520 nm). Comparative
analysis and relative protein quantification between the curcumin treated and control samples
(control vs 20 min, control vs. 60 min and control vs. 120 min curcumin treatment) was per-
formed using DeCyder 2D software, version 7.0 (GE Healthcare). Two different modules, dif-
ferential in-gel analysis (DIA) and biological variation analysis (BVA), of the DeCyder
software were used for 2D-DIGE analysis. DIA module was used for spot detection and pair-
wise comparisons of normal and curcumin treated samples to the mixed internal standard
present in each gel. Further analysis was performed using BVA module to get the variation in
protein expression between the two experimental groups (control and curcumin treated: 20/
60/ 120 min). The differentially expressed and statistically significant (p 0.05) protein spots
present in all the gels were excised and used for MS analysis.
In-gel Digestion and Protein Identification using MALDI-TOF/TOF MS
In-gel digestion of the differentially expressed protein spots (p 0.05) was performed follow-
ing the same protocol as mentioned by Shevchenko et al. and Reddy et al. with minor modifica-
tions [52, 50]. The extracted trypsin digested peptides were further processed using Zip-Tip
C18 pipette tips (Millipore, USA) following the manufacturer’s protocol for enrichment of the
peptides and removal of salts. The protein identification was performed with MALDI-TOF/
TOF mass spectrometer (AB Sciex, Framingham, MA) linked to a 4000 series explorer software
(v.3.5.3) as described previously [50]. data analysis was performed by using MASCOT version
2.1 (http://www.martixscience.com) search engine with following parameters were specified;
database- SwissProt, B. subtilis taxonomy, trypsin digestion with single missed cleavage, oxida-
tion of methionine as a variable modification and carbamidomethylation of cysteine residue as
a fixed modification, mass tolerance 75 ppm for MS and 0.4 Da for MS/MS.
In-solution Digestion, iTRAQ labelling and Peptide OFFGEL
Fractionation
Protein samples extracted from biological triplicates of control and curcumin treated (all the
three time points) B. subtilis cultures, used for DIGE analysis, were analyzed further using
iTRAQ-based quantitative proteomics. Protein in rehydration solution was exchanged to
TEAB buffer using Amicon Ultra 0.5 mL centrifugal 3 kDa filters (Millipore, Watford, UK).
After buffer exchange, biological triplicate samples (control, 20 min, 60 min and 120 min
pooled samples were pooled and quantified using QuickStart Bradford reagent (BioRad, USA).
Prior to the iTRAQ labelling, in-solution digestion was performed (100 μg proteins from each
sample) following the manufacturer’s instructions. The protein samples were reconstituted in
dissolution buffer followed by reduction with (tris (2-carboxyethyl) phosphine (TCEP)) at
60°C for 1 h and subsequently alkylated using methyl methanethiosulfonate (MMTS) for 20
min at room temperature. Trypsin (Trypsin Gold, mass spectrometry grade, Promega,
Madison, WI, USA) was added at a 1:20 trypsin: protein ratio and samples were incubated at
37° C for 16 hrs for digestion.
After in-solution digestion, iTRAQ (AB Sciex UK Limited, UK) labelling of the peptides
was performed as per the manufacturer's instructions. The labeling strategy is as follows i.e.
control-114, 20 min-115, 60 min-116 and 120 min-117 and incubated for 60 min at RT.
Temporal Proteome Analysis of B. subtilis under Curcumin Treatment
PLOS ONE | DOI:10.1371/journal.pone.0120620 April 14, 2015 20 / 27
Labelling was quenched using 100 μL of milliQ water and incubated at RT for 30 min. Peptide
OFFGEL fractionation was performed using 3100 OFFGEL fractionator (Agilent Technologies,
Santa Clara, CA) with high resolution (pH 3–10, 24 cm) IPG strip following manufacturer’s in-
struction for peptide fractionation. First, IPG strip was rehydrated for 30 min with 40 μL of re-
hydration buffer (water and pH 3–10 IPG buffer) in each well followed by adding 150 μL of
sample to each well and focusing was performed for a total of 50 kV with maximum voltage of
4000 V and 50 μA current. Each fraction was collected separately and processed using C18
STAGE tips for removal of salts and other impurities prior to the MS/MS analysis.
Q-TOF and LTQ-Orbitrap Analysis
ITRAQ-labelled samples were analyzed using two mass spectrometry platforms; Agilent 6550
QTOF and Thermo Scientific LTQ Orbitrap Velos. Quantitative proteome analysis was per-
formed using 6550 ESI Q-TOF iFunnel technology (Agilent technology, USA) coupled with
1260 Infinity HPLC-nano-chip cube controlled by MassHunter Acquisition software. The
nano chip contains analytical column (75 μm x 46 mm with 5 μm pore size) made of ZORBAX
300SB C18 with CII Filter followed by an enrichment column. Peptide sample from each frac-
tion was analyzed by loading 5 μL of sample with the flow rate of 2 μL/min of capillary pump
and 200 nL/min of nano pump. Peptide separation was performed using a gradient of 27 min;
5% sol-B at 0 min, 12% sol-B at 2 min; 30% sol-B at 20 min; 60% sol-B at 22 min, 95% sol-B at
24 min and 5% sol-B till 27 min. The acquisition parameters of mass spectrometry analysis
were as follows: positive ion mode, MS mode: m/z range from 100–3200 with MS scan rate 2
spectra/sec, MS/MS mode: scan rate 5 spectra/sec, max precursor selection is 15 with charge
state of>2 with collision energy maintained with slope-3.9 and offset-2.9.
LTQ-Orbitrap Velos mass spectrometer (Thermo Fischer Scientific, Bermen, Germany) in-
terfaced with Proxeon Easy nLC system (Thermo Scientific, Bremen, Germany) was used for
analysis of the iTRAQ-labelled OFFGEL fractionated samples. Peptides were enriched on a
trap column (75μm x 2cm) packed in-house using C18 material (Magic C18AQ, 5um, 100A,
Michrom Biosciences Inc.) with a flow rate of 3μL/min and resolved on an analytical column
(75 μm x 10 cm, Magic C18AQ, 3um, 100A, Michrom Biosciences Inc.) at a flow rate of 350
nL/min using a linear gradient of 7–30% acetonitrile over 60 min. Precursor MS scan (from m/
z 350–1,800) and MS/MS was acquired with a mass resolution of 60,000 and 15,000 at 400 m/z
in orbitrap mass analyzer. In each duty cycle twenty most intense peaks were selected for MS/
MS fragmentation using higher-energy collision dissociation (HCD) mode at 41% normalized
collision energy and isolation width was set to 1.9 m/z. Singly charged and unassigned charge
precursor were rejected. Dynamic exclusion settings were enabled and acquired ions were ex-
cluded for 45 sec. The automatic gain control for full MS and MS/MS was set to 1 × 106 and
5 × 104 ions, respectively. The maximum ion accumulation time was set to 200 msec for MS
and 300 msec for MS/MS scans. The lock mass option was enabled using polysiloxane ion (m/
z, 445.120025) from ambient air for internal calibration.
Protein Identification, Quantitation and Data Availability
Raw data obtained from both Q-TOF and LTQ-Orbitrap mass spectrometer processed using
Proteome Discoverer 1.3 (Thermo Fischer Scientific, Bermen, Germany). The data was
searched using SEQUEST algorithm against UniProt B. subtilis 168 reference protein database
having 4227 reviewed protein sequences. While performing the database search, following pa-
rameters were specified: 20 ppm precursor mass tolerance, 0.1Da fragment mass error toler-
ance, trypsin as proteolytic enzyme permissible with one missed cleavage and iTRAQ
modification at N-terminal of peptide and lysine as fixed and oxidation of methionine as
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variable modification, respectively. High peptide confidence and top peptide rank filters were
used to extract the peptide and protein data. The false discovery rate (FDR) was calculated
based on decoy database search and a cut-off of 1% was used to report identifications. Protein
data was normalized with “normalize on protein median” with minimum protein count as 20
proteins. LTQ-orbitrap mass spectrometry proteomics data have been deposited at the Proteo-
meXchange Consortium [53] via the PRIDE partner repository with the dataset identifier
PXD000644.
Functional Pathway Analysis
The differentially expressed B. subtilis proteins identified in both quantitative iTRAQ analysis
with similar trend (1% FDR, fold change- 1.5) were further subjected to in silico analysis using
DAVID version 6.7 (Database for Annotation, Visualization and Integrated Discovery; http://
david.abcc.ncifcrf.gov/home.jsp) and KOBAS 2.0 (KEGG Orthology Based Annotation System;
http://kobas.cbi.pku.edu.cn/home.do) [54, 55]. The pathway analysis of DAVID module was
used to build the pathways associated with the differentially expressed proteins indentified in
B. subtilis after curcumin treatment. In addition, pathways were built through KOBAS v 2.0
using the UniProt accession IDs of the differentially expressed candidates identified from all
three different time points (fold change -1.5 and 1% FDR) [56].
Resazurin Microtiter Assay for Metabolic Activity
Resazurin assay was performed as described by Mariscal et al., to check the cell viability and
metabolic activity of B. subtilis after curcumin treatment [57]. Triplicates of control and IC50
(20 μM) curcumin treated B. subtilis cultures at 20 min, 60 min and 120 min were harvested.
Optical density of the culture was measured for determining the cell population. Cultures were
diluted with PBS buffer and four different dilutions having cell population from 106 to 108
cells/ mL were used for the assay. Resazurin stock was added to the each sample and the fluo-
rescence intensity of resorufin was monitored at 590 nm for every 15 sec for next 30 min in a
real-time PCR machine (MyiQ2 system, BioRad, USA). Mean values of curcumin treated and
control groups were compared by using Student's t-test test and a p-value< 0.05 was consid-
ered as statistically significant.
Respiratory Activity Assay using CTC
Respiratory activity assay using 5-Cyano-2,3-di-(p-tolyl)tetrazolium chloride (CTC) was per-
formed as described by Rodriguez et al.,[58]. 50 mM stock of CTC (5-cyano-2,3-ditolyl tetrazo-
lium chloride) was prepared in ultrapure water and the final concentration of 5 mM was used
for the assay. Control and curcumin treated (20 min, 60 min and 120 min) cultures were used
for the assay after washing the pellets with PBS buffer. CTC stock (100 μL) was added to
900 μL of the cultures dispersed in PBS buffer and incubated at 37°C for 30 min in dark condi-
tion with mild agitation. Then, the cultures were fixed with 2.8% formaldehyde and 0.04% glu-
taraldehyde, and counter stained with DPAI (1 μg/mL) and incubated on ice for 20 min.
Negative control was prepared by disrupting the membrane with 2.8% formaldehyde and
0.04% glutaraldehyde for 30 min prior to the addition of CTC and subsequently counter
stained with DAPI (1 μg/mL). Stained B. subtilis cultures (curcumin treated and untreated, and
negative control) were subjected to FACS (fluorescence-activated cell sorting) analysis (FACS
Aria; Becton Dickinson, San Jose, CA, USA). The instrument was operated on logarithmic
scale by keeping rest of the parameters fixed. Blue (358 nm) and red fluorescence (630 nm) la-
sers were used for DAPI and CTC, respectively. FACS data analysis was performed using
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Cyflogic flow cytometry data analysis software, version 1.2.1 (http://www.cyflogic.com/) after
measuring total 20,000 events.
Measurement of Potassium and Phosphate Release after Drug
Treatment
Potassium (K+) and inorganic phosphate (P) leakage measurement was performed using In-
ductively Coupled Plasma—Atomic Emission Spectrometer (ICP-AES). B. subtilis cultures
were grown till mid-exponential phase. The cells were harvested by centrifugation and the pel-
let was washed four times with Na-HEPES buffer (pH 7.0) and then resuspended in same buff-
er. Bacterial cultures were inoculated into Na-HEPES buffer having 10 mM glucose with a final
OD600 of 1.0. Curcumin (IC50 and 2X IC50) treated and untreated culture having only DMSO
(as a control) were analyzed by K+ and P leakage assay. Samples were collected at 20 min, 60
min, 90 min and 120 min time intervals from both IC50 and 2 x IC50 treated samples after the
addition of curcumin. Positive control was prepared by heating the control samples for 30 min
at 70°C [59]. The cells were pelleted down by centrifugation at 10,000 x g for 10 min and the
supernatant was collected for measuring the extracellular potassium and phosphate levels
using ICP-AES. The standard curve was prepared for both K+ and P and used it for measuring
unknown concentrations.
Quantitative RT-PCR for Expression Analysis
B. subtilis AH75 cultures treated with IC50 curcumin at 20, 60 and 120 min and untreated con-
trol cultures (20 mL culture each) were used for total RNA extraction using TRIzol reagent
(Invitrogen, USA). Quality of the extracted RNA was evaluated on denatured 1% agarose gel
and by measuring the spectrometric 260/280 ratio in a Nanodrop (Implen, Germany). cDNA
synthesis was performed with 4 μg of total RNA by using RevertAid first strand kit (Fermentas,
Europe) following the manufacturer’s protocol. Prior to real-time expression analysis, quality
of cDNA synthesis was checked with PCR using designed primers (Table 3). The real-time ex-
pression analysis for selected genes (MurAA, FtsH and SpoVG) was performed using Eco real-
time PCR system (Eco real Time PCR, Illumina). Following setting was used for RT-PCR:
denaturing step at 95°C for 5 min and 40 cycles of 95°C for 30 sec, annealing at 46°C for 30 sec
and extension at 72°C for 30 sec followed by melting curve for 15 sec at 95°C, 15 sec at 46°C
and finally 95°C for 15 sec. Analysis of expression levels of the genes was carried as a relative
quantification by taking 16S rRNA as an internal control to normalize the data among the
different triplicates.
Biosensor-based Interaction Analysis
BIAcore T200 system (GE healthcare) was used to study the interaction between FtsZ and cur-
cumin. The purified FtsZ was immobilized on a CM5 sensor chip using amino coupling chem-
istry (5000 RU). Eight different concentrations of curcumin (1.25, 2.5, 5, 10, 20, 40, 80 and
Table 3. List of the primers used for quantitative RT-PCR analysis for selected genes.
Gene Forward primer (5'-3') Reverse primer (5'-3') Annealing temperature (°C) Amplicon size (bp)
MurAA 5'TACAGGTCATGCAAGAGT-3' 5'TTCTCTGTAGCTCCTACACT-3' 46 196 bp
FtsH 5'CACCGTTATCGGTCTCGTTT-3' 5'CCAAGAGGCCGACAATTTTA-3' 46 158 bp
SpoVG 5'TTCGTGTGATTGATGGAAACA-3' 5'TGCTTCAGTGTCACCCAGAC -3' 46 164 bp
16S r RNA 5'GATCTTAGTTGCCAGCATTC-3' 5'TTACTAGCGATTCCAGCTTC-3' 46 233 bp
doi:10.1371/journal.pone.0120620.t003
Temporal Proteome Analysis of B. subtilis under Curcumin Treatment
PLOS ONE | DOI:10.1371/journal.pone.0120620 April 14, 2015 23 / 27
160 μM and 40 μM used in duplicate) were injected with 1.05X HBS-EP+ in 5% DMSO buffer
(10 mMHEPES, 150 mMNaCl, 3 mM EDTA, 0.005% surfactant P40, pH 7.4) with flow rate of
30 μl/min, contact time 120 sec and dissociation time 300 sec. The interactions were monitored
in a real-time manner by measuring the response unit (RU). A mock surface was also used to
see the binding of curcumin to the matrix (CM-5 sensor chip surface) and the analyzed results
were subtracted from the blank surface. In addition, we have made solvent correction curve
with DMSO (4.5% and 5.8% DMSO) to normalize the results (curcumin was dissolved in 5%
DMSO).
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